FMD-Specific Multidisciplinary Rehabilitation vs. Conventional MS Rehabilitation

A study is planned to examine the prevalence of Functional Motor Disorder-Multiple Sclerosis overlap among participants with acute neurological symptom worsening, comparing outcomes of FMD-specific rehabilitation to conventional MS rehabilitation, followed up at three months. No results are currently available, as findings will be disseminated later.

Tags: #MSResearch
Most relevant to: —
Source: Read original source

This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.

Why it matters

This research could provide insights into the effectiveness of tailored rehabilitation approaches for individuals with overlapping symptoms of Functional Motor Disorder and Multiple Sclerosis, which may enhance treatment strategies in the future.

What this does not prove

No results are available at this time; therefore, conclusive findings cannot be established from this record.

Next milestone

No next milestone was established from the available source.

Study facts

Study design: Not reported
Participants / samples: Not reported
Randomised: Not reported
Controlled: Not reported
Primary endpoint met: Not reported
Relevant MS type: Not reported
Publication date: Not reported
Evidence reviewed: Trial registry record
Regulatory approval: Not reported
Research areas: Not classified

Original sources

Trial registrationBridging Gaps in the Multidimensional Assessment and Management of Overlapping Symptoms in Multiple Sclerosis and Functional Motor Disorders: Prevalence and Rehabilitation Effectiveness ↗

Supporting passages (7)

sample size basisPlanned enrolment

interventionThe change from baseline will be compared between the FMD-specific multidisciplinary rehabilitation arm and the conventional MS rehabilitation arm.",

comparator"Part B Active Comparator: Conventional Multiple Sclerosis Rehabilitation"

primary endpoint"measure": "Prevalence of Functional Motor Disorder-Multiple Sclerosis Overlap Among Participants Presenting With Acute Neurological Symptom Worsening",

follow upOutcomes will be assessed at baseline, immediately after the five-day intervention, and at three months.

findingsStudy results will be disseminated in aggregate or anonymized form in accordance with participant consent, Ethics Committee approval, applicable data-protection requirements, and institutional and interinstitutional agreements."

limitationsTrial registry record. Publication date: unknown. No results are posted. Planned enrolment and endpoints are not findings.

AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.